NasdaqGS - Nasdaq Real Time Price USD
Karyopharm Therapeutics Inc. (KPTI)
5.02
+0.17
+(3.51%)
As of 10:18:38 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ABATE KRISTIN Officer | Sale | Mar 4, 2025 | 9,713 |
BOHLIN GAREN G. Director | Purchase | Sep 12, 2023 | 45,140 |
CHENG SOHANYA ROSHAN Officer | Sale | Mar 4, 2025 | 34,314 |
MACOMBER LORI A Chief Financial Officer | Stock Award(Grant) | Jan 31, 2025 | 160,000 |
MANO MICHAEL General Counsel | Sale | Mar 4, 2025 | 21,047 |
MASON MICHAEL P Chief Financial Officer | Sale | Sep 4, 2024 | 391,054 |
PAKIANATHAN DEEPIKA R Director | Sale | Jun 7, 2024 | -- |
PAULSON RICHARD A. Chief Executive Officer | Sale | May 6, 2025 | 82,503 |
POULTON STUART Officer | Sale | Mar 4, 2025 | 27,414 |
RANGWALA RESHMA Officer | Sale | Apr 23, 2025 | 28,853 |
Related Tickers
MGNX MacroGenics, Inc.
1.4900
-3.87%
CHRS Coherus BioSciences, Inc.
0.7420
-6.09%
ADVM Adverum Biotechnologies, Inc.
1.8600
-9.71%
HRTX Heron Therapeutics, Inc.
1.7350
+0.87%
REPL Replimune Group, Inc.
6.93
-1.14%
FGEN FibroGen, Inc.
0.2965
-1.13%
MRSN Mersana Therapeutics, Inc.
0.3261
-14.18%
FOLD Amicus Therapeutics, Inc.
5.88
-0.09%
BTAI BioXcel Therapeutics, Inc.
1.4000
+2.21%
VSTM Verastem, Inc.
7.19
+0.84%